Steminent Biotherapeutics Inc. (TPEX:7729)
Taiwan · Delayed Price · Currency is TWD 75.10
-0.80 (-1.05%)
May 8, 2026, 1:58 PM CST
Steminent Biotherapeutics Market Cap
Steminent Biotherapeutics has a market cap or net worth of 5 billion as of May 8, 2026. Its market cap has increased by 361.46% in one year.
Market Cap
5.00B
Enterprise Value
4.57B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
75.10
Market Cap Chart
Since March 11, 2024, Steminent Biotherapeutics's market cap has increased from 2.24B to 5.00B, an increase of 123.09%. That is a compound annual growth rate of 45.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 5.00B | 24.79% |
| Dec 31, 2025 | 4.00B | 211.83% |
| Dec 31, 2024 | 1.28B | -42.67% |
| Mar 11, 2024 | 2.24B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mycenax Biotech | 5.95B |
| Sinphar Pharmaceutical | 5.85B |
| Savior Lifetec | 5.82B |
| AnnJi Pharmaceutical | 5.70B |
| Panion & Bf Biotech | 5.65B |
| UnicoCell Biomed | 5.30B |
| Senhwa Biosciences | 4.65B |
| Medigen Biotechnology | 4.61B |